Bibliography for: "Fluticasone cream generic gains tentative approval"

"Fluticasone cream generic gains tentative approval". Journal of Drugs in Dermatology. FindArticles.com. 31 Dec, 2009. http://findarticles.com/p/articles/mi_m0PDG/is_5_3/ai_n13457683/

Journal of Drugs in Dermatology

View more issues:

Articles in Sept-Oct, 2004 issue of Journal of Drugs in Dermatology

• Efficacy and irritation in the treatment of actinic keratosis with topical 5-fluorouracil
  by Javier Labandeira
• Primary prevention efforts for melanoma
  by Varee N. Poochareon
• Levamisole in dermatology: a review
• Study and treatment of inflammatory muscle diseases
• Undifferentiated connective tissue disease with various pigmentary patterns: a study of three patients
  by Iqbal A. Bukhari
• Fluticasone cream generic gains tentative approval
• Infliximab to treat dermatomyositis and polymyositis
• The excimer lasers
  by James M. Spencer
• Steroid-free pimecrolimus for monotherapy of lichen planus
  by Scott J.M. Lim
• Psoraxine enters phase II studies for moderate to severe psoriasis
• Hair loss after rhytidectomy
• Celecoxib in preventing skin cancer in patients with actinic keratoses
• FDA approves imiquimod for the treatment of superficial basal cell carcinoma
• Enoxaparin sodium-induced bullous pemphigoid-like eruption: a report of two cases
• Natural history and cause of neonatal onset multisystem inflammatory disease
• Advances in the topical treatment of acne and rosacea
  by Roger I. Ceilley
• Leflunomide as a novel treatment option in severe atopic dermatitis
• Flexural Bazex syndrome associated with tonsillar adenocarcinoma
  by M. Ali
• Combination therapy for solar lentigines
  by Patricia K. Farris
• Acambis announces halt of smallpox vaccine trial
• Utilizing combination therapy to optimize melasma outcomes
  by Marta I. Rendon
• Prednicarbate : a review
  by Aditya K. Gupta
• FDA clears marketing of commercial leeches for medicinal purposes
• Study of psoriatic arthritis
• Hylaform gel approved for the correction of moderate to severe facial wrinkles
• Effect of a one-week treatment with 0.5% topical fluorouracil on occurrence of actinic keratosis after cryosurgery. A randomized, vehicle-controlled clinical trial
• A letter from the guest editor
  by James M. Spencer
• FDA reports adverse events associated with "permanent makeup"
• Practice pearl: gargling with cholinergic ophthalmic drops for treating the oral lesions of pemphigus vulgaris
  by M.R. Namazi
• Immunomodulators for skin cancer
  by Adriana M. Villa
• Inflammation of seborrheic keratoses caused by cytarabine: a pseudo sign of Leser-Trelat
  by Timothy Patton
• Photodynamic therapy in treating patients with skin cancer
• Phase II randomized trial of arginine butyrate plus standard local therapy in patients with refractory sickle cell ulcers
• Oral isotretinoin in the treatment and prevention of cutaneous squamous cell carcinoma
  by Evan Jones
• Laser-mediated photodynamic therapy of actinic cheilitis
  by Macrene R. Alexiades-Armenakas
• The BRAF gene is frequently mutated in malignant melanoma
  by Michael R. Stratton
• Liarozole receives FDA Orphan Drug status for ichythyosis
• Follow-up protocol for patients with cancer/AIDS/skin disease
• Combination therapy in clinical and cosmetic dermatology: the marriage of device and drug
  by Mark Steven Nestor
• Aesgen completes phase III trial of Saforis in the treatment of oral mucositis
• ZD1839 for recurrent or metastatic squamous cell carcinoma of the skin
• Acneiform eruption induced by Iressa tablets used to treat non-small cell lung cancer
  by Molly M. Warthan
• Pharming enters phase III trials for rhC1INH for hereditary angioedema
• Anakinra to treat patients with neonatal onset multisystem inflammatory disease
• Computerized image analysis of nails affected by fungal infection: evaluation using digital photographs and manually defined areas
  by Robert Baran
• Facial enhancement and the European experience with Sculptra™
  by Danny Vleggaar
• Unilateral trichomegaly induced by bimatoprost ophthalmic solution
  by Nancy Hempstead
• Topical imiquimod compared with surgery in treating patients with basal cell skin cancer
• Phase II trial of Allovectin-7®, for metastatic melanoma